TAMS have been shown to induce an EMT program in pancreatic cancer cells in response to TLR4 signaling by producing IL-10 (69), and in a breast cancer model, TAMs induced EMT in cancer cells via upregulation of CCL18 (70). The gene discussed is CCL18; the disease is breast cancer.